262 related articles for article (PubMed ID: 22079173)
1. Clinical protection, sub-clinical infection and persistence following vaccination with extinction payloads of O1 Manisa Foot-and-Mouth Disease monovalent vaccine and challenge in goats and comparison with sheep.
Madhanmohan M; Nagendrakumar SB; Kumar R; Anilkumar J; Manikumar K; Yuvaraj S; Srinivasan VA
Res Vet Sci; 2012 Oct; 93(2):1050-9. PubMed ID: 22079173
[TBL] [Abstract][Full Text] [Related]
2. Effect of FMD vaccine antigen payload on protection, sub-clinical infection and persistence following needle challenge in sheep.
Madhanmohan M; Nagendrakumar SB; Narasu ML; Srinivasan VA
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e7-13. PubMed ID: 19896714
[TBL] [Abstract][Full Text] [Related]
3. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
[TBL] [Abstract][Full Text] [Related]
5. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.
Horsington J; Zhang Z; Bittner H; Hole K; Singanallur NB; Alexandersen S; Vosloo W
Vaccine; 2015 Jan; 33(3):422-9. PubMed ID: 25483241
[TBL] [Abstract][Full Text] [Related]
6. Protection against direct in-contact challenge following foot-and-mouth disease vaccination in sheep and goats: the effect on virus excretion and carrier status.
Madhanmohan M; Nagendrakumar SB; Srinivasan VA
Vet Res Commun; 2010 Mar; 34(3):285-99. PubMed ID: 20352490
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
[TBL] [Abstract][Full Text] [Related]
8. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Paton DJ; Barnett PV
Vaccine; 2005 Jan; 23(9):1106-13. PubMed ID: 15629353
[TBL] [Abstract][Full Text] [Related]
9. Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep.
Barnett PV; Keel P; Reid S; Armstrong RM; Statham RJ; Voyce C; Aggarwal N; Cox SJ
Vaccine; 2004 Mar; 22(9-10):1221-32. PubMed ID: 15003651
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.
Nagendrakumar SB; Srinivasan VA; Madhanmohan M; Yuvaraj S; Parida S; Di Nardo A; Horsington J; Paton DJ
Vaccine; 2011 Feb; 29(10):1906-12. PubMed ID: 21236232
[TBL] [Abstract][Full Text] [Related]
11. Cedivac-FMD can be used according to a marker vaccine principle.
Chénard G; Selman P; Dekker A
Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
[TBL] [Abstract][Full Text] [Related]
12. A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats.
Boshra H; Truong T; Nfon C; Bowden TR; Gerdts V; Tikoo S; Babiuk LA; Kara P; Mather A; Wallace DB; Babiuk S
Antiviral Res; 2015 Nov; 123():39-49. PubMed ID: 26341190
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of high-potency FMDV O
Horsington J; Perez CB; Maradei E; Novo SG; Gonzales JL; Singanallur NB; Bonastre P; Vosloo W
Vaccine; 2017 Sep; 35(38):5179-5185. PubMed ID: 28789849
[TBL] [Abstract][Full Text] [Related]
14. Immune Response in Goats to Different Payloads of FMDV Monovalent Vaccine: Protection Against Virulent Challenge and Development of Carrier Status.
Madhanmohan M; Nagendrakumar SB; Santhakumar P; Thiagarajan D; Lakshmi Narasu M; Srinivasan VA
Indian J Microbiol; 2011 Jan; 51(1):88-93. PubMed ID: 22282634
[TBL] [Abstract][Full Text] [Related]
15. Immune responses of sheep to quadrivalent double emulsion foot-and-mouth disease vaccines: rate of development of immunity and variations among other ruminants.
Patil PK; Bayry J; Ramakrishna C; Hugar B; Misra LD; Prabhudas K; Natarajan C
J Clin Microbiol; 2002 Nov; 40(11):4367-71. PubMed ID: 12409434
[TBL] [Abstract][Full Text] [Related]
16. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
Moraes MP; Segundo FD; Dias CC; Pena L; Grubman MJ
Vaccine; 2011 Nov; 29(51):9431-40. PubMed ID: 22027486
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and sero-conversion after vaccination against Peste des Petits Ruminants in sheep and goats from Awash Fentale District, Afar, Ethiopia.
Faris D; Yilkal A; Berhe G; Kelay B
Prev Vet Med; 2012 Feb; 103(2-3):157-62. PubMed ID: 22088269
[TBL] [Abstract][Full Text] [Related]
18. Studies on the immune response of foot-and-mouth disease vaccine type Asia-1 in pregnant ewes, lambs and evaluation of type O vaccine by challenge.
Nair SP; Sen AK
Acta Virol; 1994 Oct; 38(5):257-61. PubMed ID: 7725999
[TBL] [Abstract][Full Text] [Related]
19. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
[TBL] [Abstract][Full Text] [Related]
20. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.
Cox SJ; Parida S; Voyce C; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2007 Nov; 25(44):7687-95. PubMed ID: 17913309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
